2-es típusú cukorbetegség: vizsgálatok itt: Kína
193 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
- Where
- Yueyang
- Életkor
- 18 év to 75 év
- People
- 800
- Run by
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07082114 - No phaseTaking peopleLiver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)
- Where
- Changsha, Yichang
- Életkor
- 18 év and over
- People
- 120
- Run by
- State Key Laboratory of Subhealth Intervention Technology
See details and how to joinNCT07083336 - 4. fázisTaking peopleThe Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy
- Where
- Shanghai
- Életkor
- 50 év to 70 év
- People
- 64
- Run by
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06818851 - No phaseTaking peopleCounty Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
- Where
- Liuzhou, Sanming
- Életkor
- 40 év to 70 év
- People
- 2560
- Run by
- Peking University
See details and how to joinNCT06302127 - No phaseTaking peopleAn Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes
- Where
- Beihai, Guilin, Nanning, Qingdao
- Életkor
- 18 év to 80 év
- People
- 10 000
- Run by
- Second Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT06959030 - No phaseTaking peopleRemote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
- Where
- Beijing
- Életkor
- 40 év to 80 év
- People
- 68
- Run by
- Xuxiang Zhang, MD
See details and how to joinNCT06713720 - 4. fázisTaking peopleCofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 170
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07019012 - No phaseNot yet taking people in KínaDCB for CAD With Type 2 Diabetes
- Where
- Kaifeng, Luoyang, Ningbo, Shanghai, Yibin, Zhengzhou
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Shanghai 10th People's Hospital
See details and how to joinNCT07009938 - No phaseTaking peopleAccelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
- Where
- Ningbo
- Életkor
- 20 év to 90 év
- People
- 2720
- Run by
- Ningbo No. 1 Hospital
See details and how to joinNCT06984510 - No phaseCsak meghívásosEffect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- Shanghai East Hospital
See details and how to joinNCT06924697 - No phaseTaking peopleStudy on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression
- Where
- Nantong
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT06979440 - 1. fázisNot yet taking people in KínaA Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
- Where
- Beijing
- Életkor
- 18 év to 60 év
- People
- 30
- Run by
- Gan & Lee Pharmaceuticals.
See details and how to joinNCT06974487 - No phaseTaking peopleEffects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
- Where
- Suzhou
- Életkor
- 65 év and over
- People
- 5600
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT05349955 - No phaseTaking peopleComparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
- Where
- Beijing, Changchun, Guangzhou, Harbin, Luzhou, Nanjing, Tianjin, Xi'an, Xuzhou, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 115
- Run by
- Beijing Hospital
See details and how to joinNCT03987308 - 4. fázisTaking peopleMetformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
- Where
- Beijing
- Életkor
- 30 év to 75 év
- People
- 356
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT06932874 - 3. fázisNot yet taking people in KínaNew Triple Therapy in Newly Diagnosed Type 2 Diabetes
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 296
- Run by
- Sun Yat-sen University
See details and how to joinNCT06946628 - 4. fázisCsak meghívásosA Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 170
- Run by
- Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT06925334 - No phaseTaking peopleEvaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 300
- Run by
- Second Affiliated Hospital of Soochow University
See details and how to joinNCT06838416 - No phaseTaking peopleCharacteristics of Papez Loop Neural Network in T2DM (Type 2 Diabetes Mellitus)
- Where
- Nanjing
- Életkor
- 45 év to 70 év
- People
- 400
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06912321 - No phaseTaking peopleEfficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
- Where
- Hangzhou
- Életkor
- 18 év to 74 év
- People
- 80
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06863532 - 2/3. fázisNot yet taking people in KínaEfficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 60
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT06847178 - 3. fázisTaking peopleCurrent Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06825182 - 4. fázisTaking peopleLiraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
- Where
- Xiamen
- Életkor
- 18 év to 75 év
- People
- 164
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT03087032 - 4. fázisNot yet taking people in KínaHenagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 190
- Run by
- Xiqiao Zhou
See details and how to joinNCT06762223 - 3. fázisTaking peopleLiraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
- Where
- Nanjing
- Életkor
- 60 év and over
- People
- 260
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06361238